Verona Pharma Plc ADR (NASDAQ: VRNA): Stock Investors Should Also Pay Attention To This Stock
During the last session, Verona Pharma Plc ADR (NASDAQ:VRNA)’s traded shares were 0.89 million, with the beta value of the company hitting 0.42. At the
During the last session, Verona Pharma Plc ADR (NASDAQ:VRNA)’s traded shares were 0.89 million, with the beta value of the company hitting 0.42. At the
Verona Pharma Plc ADR (NASDAQ:VRNA)’s traded shares stood at 0.48 million during the latest session, with the company’s beta value hitting 0.45. At the last
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.